Literature DB >> 25346637

Seizing an opportunity for the endocannabinoid system.

Bradley E Alger1.   

Abstract

Exogenous cannabinoids can limit seizures and neurodegeneration, and their actions are largely mimicked by endogenous cannabinoids (endocannabinoids). Endocannabinoids are mobilized by epileptiform activity and in turn influence this activity by inhibiting synaptic transmission; both excitatory and some inhibitory synapses can be suppressed, leading to potentially complex outcomes. Moreover, the endocannabinoid system is not a fixed entity, and its strength can be enhanced or reduced. Endocannabinoids and their receptors are altered by epileptic seizures in ways that can reduce the efficacy of both exogenous and endogenous cannabinoids in sometimes unexpected ways.

Entities:  

Year:  2014        PMID: 25346637      PMCID: PMC4189640          DOI: 10.5698/1535-7597-14.5.272

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN: 1535-7511            Impact factor:   7.500


  48 in total

1.  Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy.

Authors:  Laxmikant S Deshpande; Sompong Sombati; Robert E Blair; Dawn S Carter; Billy R Martin; Robert J DeLorenzo
Journal:  Neurosci Lett       Date:  2006-11-15       Impact factor: 3.046

Review 2.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

3.  The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors.

Authors:  William R Marrs; Jacqueline L Blankman; Eric A Horne; Aurore Thomazeau; Yi Hsing Lin; Jonathan Coy; Agnes L Bodor; Giulio G Muccioli; Sherry Shu-Jung Hu; Grace Woodruff; Susan Fung; Mathieu Lafourcade; Jessica P Alexander; Jonathan Z Long; Weiwei Li; Cong Xu; Thomas Möller; Ken Mackie; Olivier J Manzoni; Benjamin F Cravatt; Nephi Stella
Journal:  Nat Neurosci       Date:  2010-07-25       Impact factor: 24.884

Review 4.  Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids.

Authors:  Laura J Sim-Selley
Journal:  Crit Rev Neurobiol       Date:  2003

5.  Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses.

Authors:  Jimok Kim; Bradley E Alger
Journal:  Nat Neurosci       Date:  2010-03-28       Impact factor: 24.884

6.  Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells.

Authors:  T A Pitler; B E Alger
Journal:  J Neurosci       Date:  1992-10       Impact factor: 6.167

7.  Anticonvulsant activity of four oxygenated cannabidiol derivatives.

Authors:  E A Carlini; R Mechoulam; N Lander
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1975-09

Review 8.  Endocannabinoid signaling as a synaptic circuit breaker in neurological disease.

Authors:  István Katona; Tamás F Freund
Journal:  Nat Med       Date:  2008-09-05       Impact factor: 53.440

9.  Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy.

Authors:  Robert E Blair; Laxmikant S Deshpande; Sompong Sombati; Maurice R Elphick; Billy R Martin; Robert J DeLorenzo
Journal:  Neuropharmacology       Date:  2009-06-18       Impact factor: 5.250

10.  Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome.

Authors:  Kwang-Mook Jung; Marja Sepers; Christopher M Henstridge; Olivier Lassalle; Daniela Neuhofer; Henry Martin; Melanie Ginger; Andreas Frick; Nicholas V DiPatrizio; Ken Mackie; Istvan Katona; Daniele Piomelli; Olivier J Manzoni
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

View more
  7 in total

Review 1.  Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.

Authors:  Evan C Rosenberg; Pabitra H Patra; Benjamin J Whalley
Journal:  Epilepsy Behav       Date:  2017-02-09       Impact factor: 2.937

2.  The Highs and Lows of the Endocannabinoid System-Another Piece to the Epilepsy Puzzle?

Authors:  Jerzy P Szaflarski
Journal:  Epilepsy Curr       Date:  2018 Sep-Oct       Impact factor: 7.500

Review 3.  Marijuana Use in Pregnancy and While Breastfeeding.

Authors:  Torri D Metz; Laura M Borgelt
Journal:  Obstet Gynecol       Date:  2018-11       Impact factor: 7.661

Review 4.  Cannabinoids and Epilepsy.

Authors:  Evan C Rosenberg; Richard W Tsien; Benjamin J Whalley; Orrin Devinsky
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

5.  Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling.

Authors:  Oihane Abiega; Sol Beccari; Irune Diaz-Aparicio; Agnes Nadjar; Sophie Layé; Quentin Leyrolle; Diego Gómez-Nicola; María Domercq; Alberto Pérez-Samartín; Víctor Sánchez-Zafra; Iñaki Paris; Jorge Valero; Julie C Savage; Chin-Wai Hui; Marie-Ève Tremblay; Juan J P Deudero; Amy L Brewster; Anne E Anderson; Laura Zaldumbide; Lara Galbarriatu; Ainhoa Marinas; Maria dM Vivanco; Carlos Matute; Mirjana Maletic-Savatic; Juan M Encinas; Amanda Sierra
Journal:  PLoS Biol       Date:  2016-05-26       Impact factor: 8.029

6.  Fatty Acid-Binding Protein 5 Modulates Brain Endocannabinoid Tone and Retrograde Signaling in the Striatum.

Authors:  Mohammad Fauzan; Saida Oubraim; Mei Yu; Sherrye T Glaser; Martin Kaczocha; Samir Haj-Dahmane
Journal:  Front Cell Neurosci       Date:  2022-07-07       Impact factor: 6.147

Review 7.  The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models.

Authors:  Jon Egaña-Huguet; Edgar Soria-Gómez; Pedro Grandes
Journal:  Int J Mol Sci       Date:  2021-12-08       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.